跳至主要内容
临床试验/JPRN-jRCT1032230171
JPRN-jRCT1032230171招募中3 期

Multicenter Randomized Controlled Trial of Endoscopic Stenting with Duckbill type Anti-Reflux Metal Stent vs Conventional Covered Metal Stent for Malignant Distal Biliary Obstruction after Dysfunction of Previous Covered Metal Stent in Unresectable Pancreatic Cancer - RESTART trial

Sasahira Naoki0 个研究点目标入组 154 人开始时间: 2023年6月25日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
154

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • 1)Unresectable pancreatic cancer
  • 2)Prior history of one endoscopic stenting with covered metal stent
  • 3)Dysfunction of previous covered metal stent
  • 4)Age >= 18 years
  • 5)Performance status of 0-2
  • 6)Expected survival time over 3 months
  • 7)Sufficient organ function
  • 1.Neutrophil count >= 1,000 /microL
  • 2.Hemoglobin level >= 7.0 g/dL
  • 3.Platelet count >= 50,000 /microL
  • 4.Total bilirubin level =< 10 mg/dL
  • 5.Aspartate aminotransferase level =< 300 U/L
  • 6.Alanine aminotransferase level =< 300 U/L
  • 7.Creatinine level =< 2.0 mg/dL
  • 8)Patients who provided a written consent

排除标准

  • 1)Concomitant hilar biliary obstruction
  • 2)Patients who require more than one biliary stent
  • 3)Unable to remove the previous covered metal stent
  • 4)Surgically altered anatomy other than Billroth 1 reconstruction
  • 5)Indwelling Pholangitis
  • 7)Cholecystitis requiring gallbladder drainage
  • 8)Liver abscess requiring abscess drainage
  • 9)Liver failure
  • 10)Indwelling gastroduodenal stent covering the duodenal papilla
  • 11)Uncontrolled gastrointestinal obstruction
  • 12)Massive ascites requiring palliative paracentesis
  • 13)Patients who would become lost to follow up right after metal stent placement
  • 14)Patients who are pregnant or may become pregnant
  • 15)Patients who are considered inappropriate by the investigator

研究者

发起方
Sasahira Naoki

相似试验